Dr Julie Blair

Senior Research Fellow
Medicine, Concord Clinical School
ANZAC Research Institute

Telephone +61 2 9767 9163
Fax +61 2 9767 9101

Map

Selected grants

2007

  • Leica CM3050 S cryostat; Seibel M, Blair J, Dunstan C, Handelsman D, Nicholson G, Kennerson M, Lowe H, Witting P, Allan C, Zhou H; University of Sydney/Major Equipment.

2006

  • KODAK Image Station 2000mm Multi-Modal Imager; Seibel M, Nicholson G, Witting P, Le Couteur D, Freedman B, Dunstan C, Blair J, Kennerson M, Myers S, Muller M; University of Sydney/Major Equipment.

2005

  • Bone resorption in breast cancer metastasis; Blair J, Dunstan C, Seibel M, Zhou H; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Dunstan, C., Blair, J., Zhou, H., Seibel, M. (2007). Bone, Mineral, Connective Tissue Metabolism. In Taylor J; Triggle D (vol ed Michael Williams) (Eds.), Comprehensive Medicinal Chemistry II, (pp. 495-520). Oxford, United Kingdom: Elsevier.

Journals

  • Blair, J., Modzelewski, J., Perryman, L., Russell, P., Seibel, M., Dunstan, C. (2009). Prolonged Antiresorptive Treatment of Lytic Prostate Cancer Xenografts in Mouse Bone Results in Tumor Necrosis. Journal of Cancer Molecules, 4(6), 175-181.
  • Zheng, Y., Zhou, H., Modzelewski, J., Kalak, R., Blair, J., Seibel, M., Dunstan, C. (2007). Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Research, 67(19), 9542-9548. [More Information]
  • Vandyke, K., Jackson, P., Rowe, A., Russell, P., Blair, J. (2007). Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate Cancer and Prostatic Diseases, 10(2), 160-166. [More Information]
  • Zheng, Y., Brennan, K., Blair, J., Modzelewski, J., Seibel, M., Dunstan, C. (2006). Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone, 40(2), 471-478. [More Information]
  • Blair, J., Zhou, H., Seibel, M., Dunstan, C. (2006). Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nature Clinical Practice Oncology, 3(1), 41-49. [More Information]
  • Blair, J., Zheng, Y., Dunstan, C. (2006). RANK ligand. The International Journal of Biochemistry and Cell Biology, 39(6), 1077-1081. [More Information]
  • Blair, J., Lehrer, G. (2001). Cohomology actions and centralisers in unitary reflection groups. Proceedings of the London Mathematical Society, 83(3), 582-604.

Conferences

  • Seibel, M., Blair, J., Perryman, L., Pwint, H., Lelliott, J., De Winter, J., Russell, P., Dunstan, C. (2005). Osteoprotegerin treatment inhibits the growth of lytic prostate cancer lesions in bone. 2nd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society, New York: Elsevier Science.

2009

  • Blair, J., Modzelewski, J., Perryman, L., Russell, P., Seibel, M., Dunstan, C. (2009). Prolonged Antiresorptive Treatment of Lytic Prostate Cancer Xenografts in Mouse Bone Results in Tumor Necrosis. Journal of Cancer Molecules, 4(6), 175-181.

2007

  • Zheng, Y., Zhou, H., Modzelewski, J., Kalak, R., Blair, J., Seibel, M., Dunstan, C. (2007). Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Research, 67(19), 9542-9548. [More Information]
  • Vandyke, K., Jackson, P., Rowe, A., Russell, P., Blair, J. (2007). Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate Cancer and Prostatic Diseases, 10(2), 160-166. [More Information]
  • Dunstan, C., Blair, J., Zhou, H., Seibel, M. (2007). Bone, Mineral, Connective Tissue Metabolism. In Taylor J; Triggle D (vol ed Michael Williams) (Eds.), Comprehensive Medicinal Chemistry II, (pp. 495-520). Oxford, United Kingdom: Elsevier.

2006

  • Zheng, Y., Brennan, K., Blair, J., Modzelewski, J., Seibel, M., Dunstan, C. (2006). Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone, 40(2), 471-478. [More Information]
  • Blair, J., Zhou, H., Seibel, M., Dunstan, C. (2006). Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nature Clinical Practice Oncology, 3(1), 41-49. [More Information]
  • Blair, J., Zheng, Y., Dunstan, C. (2006). RANK ligand. The International Journal of Biochemistry and Cell Biology, 39(6), 1077-1081. [More Information]

2005

  • Seibel, M., Blair, J., Perryman, L., Pwint, H., Lelliott, J., De Winter, J., Russell, P., Dunstan, C. (2005). Osteoprotegerin treatment inhibits the growth of lytic prostate cancer lesions in bone. 2nd Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society, New York: Elsevier Science.

2001

  • Blair, J., Lehrer, G. (2001). Cohomology actions and centralisers in unitary reflection groups. Proceedings of the London Mathematical Society, 83(3), 582-604.

To update your profile click here. For support on your academic profile contact .